Expression levels of thymidine phosphorylase (TP) and dihydropyrimidine dehydrogenase (DPD) in patients with gastrointestinal cancer

Anticancer Research

Volumn 25, Issue 6 A, 2005, Pages 3755-3761

  Nakayama, Yoshifumi ^a   Inoue, Yuzuru ^a   Nagashima, Nobuo ^a   Katsuki, Takefumi ^a   Matsumoto, Kentarou ^a   Kadowaki, Koji ^a   Shibao, Kazunori ^a   Tsurudome, Yosuke ^a   Hirata, Keiji ^a   Sako, Tatsuhiko ^a   Nagata, Naoki ^a   Itoh, Hideaki ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Colorectal carcinoma; Dihydropyrimidine dehydrogenase; Gastric carcinoma; Thymidine phosphorylase

Indexed keywords

DIHYDROPYRIMIDINE DEHYDROGENASE; FLUOROURACIL; FLUOROURACIL DERIVATIVE; PYRIMIDINE NUCLEOSIDE; THYMIDINE PHOSPHORYLASE;

ADULT; AGED; CANCER LOCALIZATION; CLINICAL FEATURE; COLORECTAL CANCER; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; DIGESTIVE SYSTEM CANCER; DRUG METABOLISM; DRUG SENSITIVITY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FROZEN SECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PYRIMIDINE METABOLISM; REGULATORY MECHANISM; STOMACH CANCER; TISSUE SPECIFICITY;

AGED; COLORECTAL NEOPLASMS; DIHYDROURACIL DEHYDROGENASE (NADP); FEMALE; HUMANS; MALE; NEOPLASM STAGING; STOMACH NEOPLASMS; THYMIDINE PHOSPHORYLASE;

EID: 27844583463     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (38)

1. Saito H, Tsujitani S, Oka S, Kondo A, Ikeguchi M, Maeta M and Kaibara N: The expression of thymidine phosphorylase correlates with angiogenesis and the efficacy of chemotherapy using fluorouracil derivates in advanced gastric carcinoma. Br J Cancer 81: 484-489, 1999.
2. Furukawa T, Yoshimura A, Sumizawa T et al: Angiogenic factor. Nature 356: 667, 1992.
3. Haraguchi M, Miyadera K, Uemura K et al: Angiogenic activity of enzymes. Nature 368: 198, 1994.
4. Moghaddam A, Zhang HT, Fan TP et al: Thymidine phosphorylase is angiogenic and promotes tumor growth. Proc Natl Acad Sci USA 92: 998-1002, 1995.
5. Nishida M, Hino A, Mori K, Matsumoto T, Yoshikubo T and Ishitsuka H: Peparation of anti-human thymidine phosphorylase monoclonal antibodies useful for detecting the enzyme levels in tumor tissues. Biol Pharm Bull 19: 1407-1411, 1996.
6. Mori K, Hasegawa M, Nishida M, Toma H, Fukuda M, Kubota T, Nagasue N, Yamana H, Hirakawa-YS Chung K, Ikeda T, Takasaki K, Oka M, Kameyama M, Toi M, Fujii H, Kitamura M, Murai M, Sasaki H, Ozono S, Makuuchi H, Shimada Y, Onishi Y, Aoyagi S, Mizutani K, Ogawa M, Nakao A, Kinoshita H, Tono T, Imamoto H, Nakashima Y and Manabe T: Expression levels of thymidine phosphorylase and dihydropyrimidine dehydrogenase in various human tumor tissues. Int J Oncol 17: 33-38, 2000.
7. Ikeguchi M, Sakatani T, Ueda T, Hirooka Y and Kaibara N: Thymidine phosphorylase activity in liver tissue and its correlation with multifocal occurrence of hepatocellular carcinomas. In Vivo 15: 265-270, 2001.
8. Koide N, Nishio A, Hiraguri M, Kishimoto K, Nakamura T, Adachi W and Amano J: Differences and relationships of thymidine phosphorylase expression in tumor-associated macrophages and cancer cells in squamous cell carcinoma of the esophagus. Dis Esophagus 15: 67-73, 2002.
9. Arima J, Imazono Y, Takebayashi Y, Nishiyama K, Shirahama T, Akiba S, Furukawa T, Akiyama S and Ohi Y: Expression of thymidine phosphorylase as an indicator of poor prognosis for patients with transitional cell carcinoma of the bladder. Cancer 88: 1131-1138, 2000.
10. Morita T, Matsuzaki A and Tokue A: Quantitative analysis of thymidine phosphorylase and dihydropyrimidine dehydrogenase in renal cell carcinoma. Oncology 65: 125-131, 2003.
11. Tanaka Y, Kobayashi H, Suzuki M, Kanayama N, Suzuki M and Terao T: Thymidine phosphorylase expression in tumor-infiltrating macrophages may be correlated with poor prognosis in uterine endometrial cancer. Hum Pathol 33: 1105-1113, 2002.
12. Tokunaga Y, Hosogi H, Hoppou T, Nakagami M, Tokuka A and Ohsumi K: Prognostic value of thymidine phosphorylase/ platelet-derived endothelial cell growth factor in advanced colorectal cancer after surgery: evaluation with a new monoclonal antibody. Surgery 131: 541-547, 2002.
13. Takebayashi Y, Akiyama S, Akiba S, Yamada K, Miyadera K, Sumizawa T, Yamada Y, Murata F and Aikou T: Clinocopathologic and prognostic significance of angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma. J Natl Cancer Inst 88: 1110-1117, 1996.
14. Maeda K, Chung YS, Ogawa Y, Takatsuka S, Kang SM, Ogawa M, Sawada T, Onoda N, Kato Y and Sowa M: Thymidine phosphorylase/ platelet-derived endothelial growth factor expression associated with hepatic metastasis in gastric carcinoma. Br J Cancer 73: 884-888, 1996.
15. Koide N, Watanabe H, Yazawa K, Adachi W and Amano J: Immunohistochemical expression of thymidine phosphorylase/ platelet-derived endothelial cell growth factor in squamous cell carcinoma of the esophagus. J Hepatogastroenterology 46: 944-951, 1999.
16. Wada S, Yoshimura R, Naganuma T, Yoshida N, Narita K and Ikemoto S: Thymidine phosphorylase levels as a prognostic factor in renal cell carcinoma. BJU Int 91: 105-108, 2003.
17. Koukourakis MI, Giatromanolaki A, O'Byrne KJ, Comley M, Whitehouse RM, Talbot DC, Gatter K and Harris AL: Platelet-derived endothelial cell growth factor expression correlates with tumour angiogenesis and prognosis in non-small-cell lung cancer. Br J Cancer 75: 477-481, 1997.
18. Zhang R, Lu Z, Liu T, Soong SJ and Diasio RB: Relationship between circadian-dependent toxicity of 5-fluorodeoxyuridine and circadian rhythms of pyrimidine enzymes: possible relevance to fluoropyrimidine chemotherapy. Cancer Res 55: 2816-2822, 1993.
19. Terashima M, Fujiwara H, Takagane A, Abe K, Araya M, Irinoda T, Yonezawa H, Nakaya T, Oyama K, Takahashi M and Saito K: Role of thymidine phosphorylase and dihydropyrimidine dehydrogenase in tumour progression and sensitivity to doxifluridine in gastric cancer patients. Eur J Cancer 38: 2375-2381, 2002.
20. Hotta T, Taniguchi K, Kobayashi Y, Johata K, Sahara M, Naka T, Watanabe T, Ochiai M, Tanimura H and Tsubota YT: Preoperative endoscopic analysis of thymidine phosphorylase and dihydropyrimidine dehydrogenase in gastrointestinal cancer. Oncol Rep 11: 1233-1239, 2004.
21. Hotta T, Taniguchi K, Kobayashi Y, Johata K, Sahara M, Naka T, Watanabe T, Ochiai M, Tanimura H and Tsubota YT: Comparative analysis of thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in gastric and colorectal cancers. Oncol Rep 11: 1045-1051, 2004.
22. Hiroyasu S, Shiraishi M, Samura H, Tokashiki H, Shimoji H, Isa T and Muto Y: Clinical relevance of the concentrations of both pyrimidine nucleoside phosphorylase (PyNPase) and dihydropyrimidine dehydrogenase (DPD) in colorectal cancer. Jpn J Clin Oncol 31: 65-68, 2001.
23. Li H, Suo Z, Zhang Y, Risberg B, Karlsson MG, Villman K and Nesland JM: The prognostic significance of thymidine phosphorylase, thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expressions in breast carcinomas. Histol Histopathol 19: 129-136, 2004.
24. Horiguchi J, Yoshida T, Koibuchi Y, Iijima K, Ninomiya J, Takei H, Yokoe T, Iino Y and Morishita Y: DPD activity and immunohistochemical DPD expression in human breast cancer. Oncol Rep 11: 65-72, 2004.
25. Hotta T, Kobayashi Y, Taniguchi K, Johata K, Sahara M, Watanabe T, Ochiai M, Tanimura H and Tsubota YT: Thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in hepatocellular carcinoma and metastatic liver cancer. Oncol Rep 12: 347-351, 2004.
26. Fujiwaki R, Iida K, Nakayama K, Kanasaki H, Ozaki T, Hata K, Sakai E and Miyazaki K: Dihydropyrimidine dehydrogenase in normal and malignant endometrium: relationship with cell proliferation and thymidine phosphorylase. Virchows Arch 443: 672-677, 2003.
27. Huang CL, Yokomise H, Kobayashi S, Fukushima M, Hitomi S and Wada H: Intratumoral expression of thymidylate synthase and dihydropyrimidine dehydrogenase in non-small cell lung cancer patients treated with 5-FU-based chemotherapy. Int J Oncol 17: 47-54, 2000.
28. Toi M, Hoshina S, Taniguchi T, Yamamoto Y, Ishitsuka H and Tominaga T: Expression of platelet-derived endothelial growth factor in human breast cancer. Int J Cancer 64: 79-82, 1995.
29. Griffiths L, Dachs GU, Bicknell R, Harris AL and Stratford U: The influence of oxygen tension and pH on the expression of platelet-derived endothelial cell growth factor/ thymidine phosphorylase in human breast tumor cells grown in vitro and in vivo. Cancer Res 57: 570-572, 1997.
30. Eda H, Fujimoto K, Watanabe S et al: Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5′-deoxy-5-fluorouridine. Cancer Chemother Pharmacol 32: 333-338, 1993.
31. Endo M, Shinbori N, Fukase Y et al: Induction of thymidine phosphorylase expression and enhancement of efficacy of capecitabine or 5′-deoxy-5- fluorouridine by cyclophosphamide in mammary tumor models. Int J Cancer 53: 127-134, 1999.
32. Relf M, LeJeune S, Scott PA, Fox S, Smith K, Leek R, Moghaddam A, Whitehouse R, Bicknell R and Harris AL: Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res 57: 963-969, 1997.
33. Sivridis E, Giatromanolaki A, Gatter KC, Harris AL and Koukourakis MI: Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma. Cancer 95: 1055-1063, 2002.
34. Zhu GH, Lenzi M and Schwartz EL: The Sp1 transcription factor contributes to the tumor necrosis factor-induced expression of the angiogenic factor thymidine phosphorylase in human colon carcinoma cells. Oncogene 21: 8477-8485, 2002.
35. Johnston SJ , Ridge SA, Cassidy J and McLeod HL: Regulation dihydropyrimidine dehydrogenase in colorectal cancer. Clin Cancer Res 5: 2566-2570, 1999.
36. Shestopal SA, Johnson MR and Diasio RB: Molecular cloning and characterization of the human dihydropyrimidine dehydrogenase promoter. Biochem Biophys Acta 1494: 162-169, 2000.
37. Yoshinare K, Kubota T, Watanabe M, Wada N, Nishibori H, Hasegawa H, Kitajima M, Takechi T and Fukushima M: Gene expression in colorectal cancer and in vitro chemosensitivity to 5-fluorouracil: a study of 88 surgical specimens. Cancer Sci 94: 633-638, 2003.
38. Toi M, Ueno T, Matsumoto H, Saji H, Funata N, Koide M and Tominaga T: Significance of thymidine phosphorylase as a marker of protumor monocytes in breast cancer. Clin Cancer Res 5: 1131-1137, 1999.